Michael Rabinowitz - Net Worth and Insider Trading
Michael Rabinowitz Net Worth
The estimated net worth of Michael Rabinowitz is at least $298,959 dollars as of 2024-12-29. Michael Rabinowitz is the Chief Commercial Officer of Oramed Pharmaceuticals Inc and owns about 126,143 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $298,959. Details can be seen in Michael Rabinowitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Rabinowitz has not made any transactions after 2023-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Rabinowitz
Michael Rabinowitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Rabinowitz owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .
Click here to see the complete history of Michael Rabinowitz’s form 4 insider trades.
Insider Ownership Summary of Michael Rabinowitz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2023-01-03 | Chief Commercial Officer |
Michael Rabinowitz Latest Holdings Summary
Michael Rabinowitz currently owns a total of 1 stock. Michael Rabinowitz owns 126,143 shares of Oramed Pharmaceuticals Inc (ORMP) as of January 3, 2023, with a value of $298,959.
Latest Holdings of Michael Rabinowitz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2023-01-03 | 126,143 | 2.37 | 298,959 |
Holding Weightings of Michael Rabinowitz
Michael Rabinowitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Rabinowitz has made a total of 1 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Oramed Pharmaceuticals Inc is the sale of 13,325 shares on January 3, 2023, which brought Michael Rabinowitz around $167,229.
Insider Trading History of Michael Rabinowitz
- 1
Michael Rabinowitz Trading Performance
Michael Rabinowitz Ownership Network
Michael Rabinowitz Owned Company Details
What does Oramed Pharmaceuticals Inc do?
Who are the key executives at Oramed Pharmaceuticals Inc?
Michael Rabinowitz is the Chief Commercial Officer of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Financial Officer David Silberman , and Chief Legal Officer Netanel Derovan .
Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oramed Pharmaceuticals Inc Insider Transactions
Michael Rabinowitz Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Rabinowitz. You might contact Michael Rabinowitz via mailing address: 1185 Avenue Of The Americas, Third Floor, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
